39 net

What 39 net does

39.net (39健康网) is a privately held Chinese health information portal founded on March 9, 2000, and operated by Guangzhou Qisheng Information Technology Co., Ltd. (广州启生信息技术有限公司). It serves Chinese consumers seeking medical knowledge and care navigation, offering disease encyclopedias (19,000+ entries), diagnostic tests (3,400+), procedures (1,300+), drug records (325,560), hospital directories (38,042 facilities), pharmacy listings (61,777), and a consumer health Q&A service that has resolved more than 150 million questions, with 144,454 registered doctors participating. The platform reports 400+ million monthly unique users, making it one of the largest dedicated consumer health destinations in China.

The product is a vertically integrated web portal whose core technology is content and data aggregation rather than a single monolithic application: disease, drug, hospital, and doctor data are organized into searchable knowledge bases, and user-submitted questions are routed to registered physicians for answers. The operating entity holds CMMI3 software-process certification (re-certified through 2025) and has been designated a Chinese High-tech Enterprise five times, most recently in 2024, indicating sustained engineering and R&D investment.

The business model is B2B advertising: pharmaceutical, consumer health, and insurance brands pay to reach the platform's large consumer audience across the consumer health-research journey. Named advertisers include multinational pharma companies (GSK, Pfizer, Bayer, Eli Lilly, Wyeth, Schering-Plough), domestic pharma and TCM brands (Tasly, Buchang), consumer health (Amway), and insurance (Ping An). The firm has also positioned itself within national health-media bodies, including co-founding the Health China New Media Platform Working Committee in 2018 and partnering with the China Anti-Cancer Association for oncology content. Capital history is limited to two disclosed early-stage rounds with IDG Capital in 2006 and 2007.

Name

39 net

Legal name

广州启生信息技术有限公司

Website

https://39.net

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

11–50 employees

Short description

39.net (39健康网) is China's leading consumer health information portal, founded in 2000, serving 400M+ monthly users with medical content, doctor Q&A, hospital directories, and drug references. It monetizes through B2B advertising from pharmaceutical and consumer health brands.

Ownership category

akta.pro rank

Product category

Online Health Information Portal

SIC

Services-Health Services (8000)

akta.pro primary industry

Health, Fitness & Wellness Magazines (MPAJAEAD)

Keywords

• Online health portal
• Medical information platform
• Hospital doctor search
• Drug information database
• Health advertising network

Headquarters

HQ city

Shenzhen

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Digital Commerce or Content

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Advertising - Pharmaceutical & Healthcare: Primary revenue stream from pharmaceutical companies, healthcare brands, and medical device companies advertising on the platform. Clients include major brands like GSK, Pfizer, Bayer, Eli Lilly, Tasly, and domestic healthcare companies.
2. Advertising - Consumer Health & FMCG: Revenue from consumer health products, nutritional supplements, maternal & infant care brands, and daily chemicals. Includes brands like Amway, Wyeth, and various domestic companies.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels7 records

Core offering

39健康网 operates www.39.net, a consumer-facing online health information and services portal offering free health news, symptom self-check, doctor Q&A (39问医生 with 144,454 doctors), hospital/doctor lookup (就医助手 covering 38,042 hospitals), drug information (药品通 with 325,560 drugs), and a disease encyclopedia (疾病百科 with 19,000+ diseases). B2B revenue is generated by selling advertising, branded content, and marketing solutions to pharmaceutical, healthcare, hospital, and consumer health brands through the 39 E-Marketing Center.

Product overview

39健康网 is a comprehensive online health information and services platform providing a multi-product ecosystem covering: (1) core health search and consultation tools — 就医助手 (hospital/doctor search), 疾病百科 (disease encyclopedia), and 症状自查 (symptom checker); (2) interactive Q&A and community platforms — 39问医生 (doctor Q&A), 名医在线 (live expert consultations), 39健康问答, 39健康博客, and 39健康论坛; (3) drug information — 药品通; (4) branded content columns — 仁心, 新疆界, 健康新知, 39深呼吸, 智慧妈妈, and 39减肥达人秀; (5) specialized verticals including fitness/weight loss, parenting, beauty, and diet; and (6) B2B marketing services for pharmaceutical and healthcare companies. The platform covers 396 cities, 38,042 hospitals, 580,174 doctors, and 189 cities with monthly coverage exceeding 100 million users.

Differentiator

Problem solved

Functional benefit

Products and services

• 就医助手 (Hospital & Doctor Assistant) Precise hospital and doctor search tool covering 396 cities, 38,042 hospitals, and 580,174 doctors in China; matches users to appropriate hospitals and doctors based on disease needs through professional medical logic sorting and presentation.
• 名医在线 (Famous Doctors Online) Live online Q&A program where nationally renowned tertiary hospital chief physicians answer netizen questions on specific topics, with 764 chief physicians from 184 hospitals conducting 600+ sessions.
• 药品通 (Drug Guide) Drug information database containing 325,560 drug instruction records and 61,777 pharmacy records; provides OTC and prescription drug lookup, health products, medical devices, medication consultation, and pharmacy search services.
• 39问医生 (39 Ask a Doctor) Online health Q&A platform with 144,454 participating doctors; has resolved 150 million health questions with approximately 100,000 doctors online daily providing rapid health consultations.
• 疾病百科 (Disease Encyclopedia) Comprehensive disease database covering 19,000+ disease symptoms, 3,400+ examination/test items, and 1,300+ surgical procedures; provides disease treatment, prevention, diet, expert opinions, and authoritative hospital/doctor recommendations.
• 39营销中心 (39 E-Marketing Center) Digital marketing services arm for pharmaceutical, healthcare, hospital, and health product companies; delivers advertising, content marketing, and integrated brand promotion solutions to enterprise clients.
• 症状自查 (Symptom Self-Checker) Interactive self-diagnosis tool allowing users to select body parts, symptoms, gender, and age to identify potential causes and recommended medical departments.
• 39健康数据报告 (39 Health Data Reports) Research and data publication division providing health industry reports, market data analysis, and industry research insights.

Quantifiable outcome

• 400+ million monthly unique users reached
• +2 more outcomes

Named customers10 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Ten partnerships are on record, tiered major and core.

• 健康中国新媒体平台工作委员会majorStrategic or Co-development Partner · 19 April 2018Selected as founding member of the Health China New Media Platform Working Committee, alongside Baidu, Sina Weibo, Tencent, and NetEase, for collaborative health information promotion
• 葛兰素史克 (GSK)coreGTM or Marketing PartnerMajor pharmaceutical client running multi-year marketing campaigns for pain relief brand 芬必得 (Fenbid), featuring precise targeting of pain patients and sustained brand positioning
• 拜耳医药 (Bayer)coreGTM or Marketing PartnerHealthcare marketing partner for contraceptive product 优思明, including World Contraception Day themed campaigns and interactive engagement activities
• 辉瑞制药 (Pfizer)coreGTM or Marketing PartnerLong-term partner for biologic drug 恩利 (Enbrel), featuring large-scale public welfare activities and patient story sharing campaigns
• 礼来药业 (Eli Lilly)coreGTM or Marketing PartnerMarketing partner for men's health product 希爱力 (Cialis), implementing health communication campaigns to enhance brand affinity
• 天士力集团 (Tasly)majorGTM or Marketing PartnerStrategic partner for modern TCM health solutions, featuring authoritative content development and multi-media campaign amplification
• 惠氏制药 (Wyeth)majorGTM or Marketing PartnerMarketing partner for nutritional supplement 善存 (Centrum), featuring scientific product evaluation and multi-media promotional support
• 中国平安 (China Ping An)majorGTM or Marketing PartnerHealthcare and insurance industry marketing collaboration, targeting health-conscious consumer segments
• 安利纽崔莱 (Amway Nutrilite)majorGTM or Marketing PartnerMarketing partnership for nutritional supplement products, featuring authority-based marketing and health communication campaigns
• 中国抗癌协会 (CACA)coreStrategic or Co-development PartnerContent partnership for oncology information and awareness campaigns, featuring CACA 40th anniversary coverage and China Integrated Oncology Conference reporting

Scale indicators10 records

Recent moves6 records

Expansion highlights4 records

Emerging players

• Healthline: Digital consumer health media brand publishing original condition, nutrition, and wellness content with significant pharma/supplement ad monetization. Comparable in editorial-led health content model and B2B brand marketing GTM.
• Zocdoc: US online doctor appointment booking and provider search platform. Comparable hospital/doctor directory and online appointment functionality within 39.net's Hospital Assistant module, though geographically distinct.

Direct peers

• DXY (丁香园): China's largest professional health community and consumer health media brand with a comparable mix of health content, drug information, and B2B pharma marketing services. Directly comparable in product scope (drug database, doctor Q&A, hospital directory) and B2B monetization model.
• Hao Daifu Online (好大夫在线): Leading online platform for doctor-patient consultation and hospital/department discovery in China. Directly comparable to 39.net's hospital/doctor lookup and Ask-a-Doctor offerings, serving the same consumer health-seeking audience.
• Chunyu Doctor (春雨医生): Mobile-first online doctor consultation platform in China with significant health content and Q&A traffic. Competes with 39.net's 39 Ask a Doctor for doctor Q&A sessions and symptom-based health information consumption.
• Xunyiwenyao (寻医问药): Long-established Chinese health portal combining drug information, doctor directories, and health Q&A. Closely comparable business model to 39.net as a horizontal health information site with B2B pharma advertising.

Broad incumbents

• Ping An Good Doctor (平安健康): Listed healthcare and insurance platform combining online consultation, drug retail, and consumer health services. Overlaps with 39.net's hospital/department lookup and health-content flywheel, and is both a 39.net advertising client and adjacent competitor.
• WeDoctor (微医): Major integrated digital healthcare platform covering appointments, consultations, and insurance. Competes for hospital/doctor lookup traffic and B2B health services budgets across Chinese consumers and pharma partners.
• WebMD: US consumer health information leader providing drug databases, disease content, and doctor directories monetized via pharma/healthcare advertising. Closest international functional analog to 39.net's B2B advertiser-funded consumer portal model.
• Baidu Health: Health vertical of China's leading search engine; combines authoritative medical content, doctor Q&A, and AI health search. Directly competes for health-information queries and benefits from superior SEO distribution versus 39.net.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/39-net

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 39 net